12:00 AM
 | 
Nov 08, 2004
 |  BioCentury  |  Finance

Analyst picks & changes

Analyst picks & changes

Company Bank Analyst Coverage Opinion
BioMarin (BMRN; SWX:BMRN) SG Cowen Phil Nadeau Other In line
Nadeau raised his FY04 revenue estimate to $4.7M from $4.6M but lowered his FY05 revenue estimate to $34.8M from $45M due to recently approved generic versions of Orapred for asthma in children. BMRN closed Friday at $3.99, down $0.14 on the week.
Cephalon (CEPH) SG Cowen Eric Schmidt Other NA
Schmidt fine-tuned his FY04 revenue estimate to $994.4M from $994.5M and raised his FY05 revenue estimate to $1,275M from $1,273M. He raised his FY04 EPS estimate to $2.35 from $2.32 and lowered his FY05 EPS estimate to $2.95 from $3. CEPH closed Friday at $50.17 up $2.50 on the week.
Ciphergen (CIPH) SG...

Read the full 700 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >